Filing Details

Accession Number:
0001209191-23-027790
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-05 17:19:09
Reporting Period:
2023-05-03
Accepted Time:
2023-05-05 17:19:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1645569 Dice Therapeutics Inc. DICE Pharmaceutical Preparations (2834) 472286244
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1882035 M. Scott Robertson C/O Dice Therapeutics, Inc.
400 East Jamie Court, Suite 300
South San Francisco CA 94080
Cfo & Cbo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-05-03 18,750 $36.55 198,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 28, 2022.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.50 to $36.63 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.